We have always told the drug companies that we would not pressure them and create a slippery slope where prices they negotiate with us for poor countries would inevitably lead to similar prices in rich countries.
[...] If we do try to do something in this area, we suggest that we approach the innovator companies that can currently sell products in the US with the idea of making donations to help clear the ADAP lists. For a variety of reasons, the companies will likely favor a donation approach rather than one that erodes prices across the board.
[...] I would guess that they would also likely favor a solution that involved their drugs rather than an approach that allowed generic drugs from India to flood the US market at low prices or one that set a precedent of waiving patent laws on drugs.
Since I don't have a 4K HDR television (planned for next summer though), I'm not likely to pick up a Pro immediately. However, reviews can sway me, based on a very simple criterium: does it significantly improve PSVR. I've been extremely happy with my headset so far, but I do notice that some games look better in it than others, especially when it comes to anti-aliasing. I'm not expecting the Pro to improve upon the best experiences, but if it raises the median and average quality towards the best ones, it's day one after all.
The bigger problem with this article though is that it really doesn't belong here. This is not a technology issue, or even a science issue. This is an economics issue, and a monetary issue.
It fits "news for nerds, stuff that matters". Slashdot isn't strictly about technology.
Wishing without work is like fishing without bait. -- Frank Tyger